Pathology consultation on the laboratory evaluation of thrombophilia: when, how, and why.

Why COVID-19 Laboratory Personnel Should Be Tested Before Attending the Laboratory: how even the most experienced personnel conta350minate clinical samples

Dear Editor in Chief  Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) has resulted in a pandemic (1). Early diagnosis and testing of symptomatic individuals and asymptomatic carriers (2) remain essential since the latter group can transmit the virus (3,4). Current assays for SARS-CoV-2 detection are mostly based on quantitative real-time PCR (RT-qPCR)(5). However, cross-contaminat...

Using the Taxonomy and the Metrics: What to Study When and Why; Comment on “Metrics and Evaluation Tools for Patient Engagement in Healthcare Organization- and System-Level Decision-Making: A Systematic Review”

Dukhanin and colleagues’ taxonomy of metrics for patient engagement at the organizational and system levels has great potential for supporting more careful and useful evaluations of this ever-growing phenomenon. This commentary highlights the central importance to the taxonomy of metrics assessing the extent of meaningful participation in decision-making by patients, consumers and community mem...

The Why, Who, What, How, and When of Patient Engagement in Healthcare Organizations: A Response to Recent Commentaries

Application of qualitative research in management (why, when and how)

Application of qualitative research in management (why, when and how) Qualitative research has been increasingly used in all sciences. In this paper we will discuss about the applications of qualitative research methods in management sciences. The differences between quantitative and qualitative researches will be clarified and the statistical methods which are suitable for such researches will...

Inherited Genetic Markers for Thrombophilia in Northeastern Iran (a Clinical-Based Report)

Background: Thrombophilia is a main predisposition to thrombosis due to a procoagulant state. Several point mutations play key roles in blood-clotting disorders, which are grouped under the term thrombophilia. These thrombophilic mutations are methylenetetrahydrofolate reductase (MTHFR, C677T, and A1298C), factor V Leiden (G1691A), prothrombin gene mutation (factor II, G20210A), and plasminogen...